VevaRX review
Value Score68/100
A thirty-six-state program selling semaglutide at $189 a month on a page that also prints $167, $399 and $467 for the same drug — and tirzepatide only as a three-month prepay whose advertised per-month equivalent does not divide.
We earn a commission when you start treatment through some links on this site, at no extra cost to you. CoreAge Rx is a featured partner, and providers we work with may appear first. It never changes the Value Score.
Advertised price
From $189/mo
$189/mo month-to-month (or $399 on a three-month prepay; its own page also prints $167 a month and a $467 total)
How much does VevaRX cost?
The price VevaRX publishes is $189/mo month-to-month (or $399 on a three-month prepay; its own page also prints $167 a month and a $467 total). We flag this one to watch: confirm the ongoing rate with VevaRX before you count on it.
- Semaglutide
- $189/mo month-to-month (or $399 on a three-month prepay; its own page also prints $167 a month and a $467 total)
- Tirzepatide
- $467 per three-month prepay, auto-renewing with a three-month minimum (no monthly rate is published for tirzepatide)
- Coverage
- 36 states, listed
- Brand-name
- Compounded only
The Value Score card
VevaRX scored on our six published factors. See the methodology.
What's good
- The states are published as a named list of thirty-six rather than an all-fifty claim, and the list is the one the site treats as operative
- A month-to-month option exists for semaglutide at $189, which is more than the tirzepatide side of the same business offers
- The three-month prepay totals are stated as totals — $399 and $467 — rather than only as per-month arithmetic, so the commitment can be priced
- Auto-renewal is disclosed plainly on the product pages: the plan renews every three months and can be canceled at any time
- A legal entity is published, and side products carry published prices rather than a consultation
Read the fine print
- The semaglutide page carries four prices for one drug, and two of them belong to tirzepatide: $189 a month and $399 for three months on the cards, then $167 a month or $467 for three months in the paragraph below them
- Tirzepatide is sold only as a three-month prepay at $467 with a three-month minimum, and the per-month equivalent advertised beside it does not divide: $467 over three months is $155.67, not the $149 printed
- Every side product publishes three different figures — one on the card, one in the plan text and one in the cart — and in at least one case the card is the wrong one
- A third price ladder sits in the terms and matches nothing sold anywhere on the site
- Another brand's domain appears in the terms as the site conducting the transactions, and the contact page's questions carry a different product's copy giving dosing instructions for a powdered drink
- Two opposite return policies are published: one page says compounded medication that has shipped cannot be returned, another promises results or your money back, and the terms say something different again
- No pharmacy is named, no clinician is named, no medical group is named and no 503A or 503B designation appears anywhere across sixteen pages
- No street address is published at all, and the only phone number appears in the terms as a text-message keyword rather than a support line
The bottom line
Best for: Readers in one of the thirty-six states listed who will confirm every figure in the cart, since the cards, the plan text and the cart disagree on almost every product.
For comparison, see CoreAge Rx, a featured partner (Value Score 81/100).
Programs to compare
Compare with other deals
The programs scoring closest to VevaRX, out of 428 others we track.
Shopping VevaRX against a specific rival? We put it head to head with our featured partner on CoreAge Rx vs VevaRX, and every program that undercuts or outscores it — starting with RxPepsDirect, the closest match on score — is ranked on the VevaRX alternatives ranking.
- From $79/moRxPepsDirect— RxPepsDirect (Peptide RX LLC) is a per-vial compounded GLP-1 telehealth platform offering semaglutide/B12 from $25/vial and tirzepatide/B12 from $45/vial, dispensed through Optimal Balance Pharmacy.68/100
- From $199/moRyze Rx— Ryze Rx is a prescription telehealth platform for weight loss, TRT and peptide therapy, prescribing through board-certified physicians and shipping from US-licensed compounding pharmacies.68/100
- $190 per 30-day supply, month-to-monthNex Gen Health Rx— Compounded semaglutide at $190 and tirzepatide at $239 per thirty-day supply, advertised as $99 and $149 a month — figures that are the 360-day prepay rates, $1,188 and $1,788 charged in one go.68/100
- $179Edessa— Clean three-rung tables one click in, behind a homepage whose cheapest number is both a prepay and a different drug.68/100
- $219/mo month-to-monthARSYNL Rx— ARSYNL Rx sells compounded semaglutide at $219 a month and tirzepatide at $269, as a weekly injection or a needle-free HypoSpray, from a veteran-founded telehealth practice.67/100
- From $199/moAurelius Health Group— Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+.67/100
More programs we track (24)
- Claya68
- DrMedHealth68
- Go Vida Plena68
- InstaRX68
- Invyncible68
- June Health68
- Luci68
- Lumen Meds68
- MANÜ Telehealth68
- Premium Health68
- Regenics68
- Roen Rx68
- Corsica Health67
- DreamHug Medical67
- FeelGood67
- HealthOn67
- MyStart Health67
- NuDay Rx67
- Pomegranate Health67
- Signos67
- Silhouette MD67
- Wisp67
- Woodwork67
- Synergy Rx67
395 more are reviewed too — see every GLP-1 program we track, ranked.
Pricing and coverage on this page come from VevaRX's own website; the Value Score is our editorial judgment per the methodology."% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on VevaRX's site. Not medical advice; see our disclosure.